Skip to main content Accessibility help
×
Home

Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function

  • Elena Dale (a1), Alan L. Pehrson (a1), Theepica Jeyarajah (a1), Yan Li (a1), Steven C. Leiser (a1), Gennady Smagin (a1), Christina K. Olsen (a2) and Connie Sanchez (a1)...

Abstract

The hippocampus plays an important role in emotional and cognitive processing, and both of these domains are affected in patients with major depressive disorder (MDD). Extensive preclinical research and the notion that modulation of serotonin (5-HT) neurotransmission plays a key role in the therapeutic efficacy of selective serotonin reuptake inhibitors (SSRIs) support the view that 5-HT is important for hippocampal function in normal and disease-like conditions. The hippocampus is densely innervated by serotonergic fibers, and the majority of 5-HT receptor subtypes are expressed there. Furthermore, hippocampal cells often co-express multiple 5-HT receptor subtypes that can have either complementary or opposing effects on cell function, adding to the complexity of 5-HT neurotransmission. Here we review the current knowledge of how 5-HT, through its various receptor subtypes, modulates hippocampal output and the activity of hippocampal pyramidal cells in rodents. In addition, we discuss the relevance of 5-HT modulation for cognitive processing in rodents and possible clinical implications of these results in patients with MDD. Finally, we review the data on how SSRIs and vortioxetine, an antidepressant with multimodal activity, affect hippocampal function, including cognitive processing, from both a preclinical and clinical perspective.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function
      Available formats
      ×

Copyright

The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence . The written permission of Cambridge University Press must be obtained for commercial re-use.

Corresponding author

*Address for correspondence: Elena Dale, PhD, Lundbeck Research USA, 215 College Rd., Paramus, NJ 07652, USA. (Email: EDAL@lundbeck.com)

Footnotes

Hide All

We would like to thank Dr. Bjarke Ebert (H Lundbeck A/S) and Simon Reid (Fusion Animation, London, United Kingdom) for assistance in preparing Figure 1 of the manuscript. This research was funded by Takeda Pharmaceuticals and H. Lundbeck A/S.

Footnotes

References

Hide All
1.Femenia, T, Gomez-Galan, M, Lindskog, M, Magara, S. Dysfunctional hippocampal activity affects emotion and cognition in mood disorders. Brain Res. 2012; 1476: 5870.
2.Small, SA, Schobel, SA, Buxton, RB, Witter, MP, Barnes, CA. A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci. 2011; 12(10): 585601.
3.Bell-McGinty, S, Butters, MA, Meltzer, CC, Greer, PJ, Reynolds, CF 3rd, Becker, JT. Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. Am J Psychiatry. 2002; 159(8): 14241427.
4.Bremner, JD, Narayan, M, Anderson, ER, Staib, LH, Miller, HL, Charney, DS. Hippocampal volume reduction in major depression. Am J Psychiatry. 2000; 157(1): 115118.
5.Frodl, TS, Koutsouleris, N, Bottlender, R, et al. Depression-related variation in brain morphology over 3 years: effects of stress? Arch Gen Psychiatry. 2008; 65(10): 11561165.
6.Sheline, YI, Gado, MH, Kraemer, HC. Untreated depression and hippocampal volume loss. Am J Psychiatry. 2003; 160(8): 15161518.
7.Videbech, P, Ravnkilde, B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry. 2004; 161(11): 19571966.
8.MacQueen, GM, Campbell, S, McEwen, BS, et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci U S A. 2003; 100(3): 13871392.
9.Gorwood, P, Corruble, E, Falissard, B, Goodwin, GM. Toxic effects of depression on brain function: impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients. Am J Psychiatry. 2008; 165(6): 731739.
10.Harvey, PO, Fossati, P, Pochon, JB, et al. Cognitive control and brain resources in major depression: an fMRI study using the n-back task. Neuroimage. 2005; 26(3): 860869.
11.Walsh, ND, Williams, SC, Brammer, MJ, et al. A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biol Psychiatry. 2007; 62(11): 12361243.
12.Hammar, A, Ardal, G. Cognitive functioning in major depression—a summary. Front Hum Neurosci. 2009; 3: 26.
13.Lee, RS, Hermens, DF, Porter, MA, Redoblado-Hodge, MA. A meta-analysis of cognitive deficits in first-episode major depressive disorder. J Affect Disord. 2012; 140(2): 113124.
14.Porter, RJ, Bourke, C, Gallagher, P. Neuropsychological impairment in major depression: its nature, origin and clinical significance. Aust N Z J Psychiatry. 2007; 41(2): 115128.
15.Hasselbalch, BJ, Knorr, U, Kessing, LV. Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review. J Affect Disord. 2011; 134(1–3): 2031.
16.Campbell, S, MacQueen, G. The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci. 2004; 29(6): 417426.
17.Biringer, E, Rongve, A, Lund, A. A review of modern antidepressants’ effects on neurocognitive function. Cur Psychiatr Rev. 2009; 5(3): 164174.
18.McIntyre, RS, Cha, DS, Soczynska, JK, et al. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety. 2013; 30(6): 515527.
19.Vythilingam, M, Vermetten, E, Anderson, GM, et al. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry. 2004; 56(2): 101112.
20.Fanselow, MS, Dong, HW. Are the dorsal and ventral hippocampus functionally distinct structures? Neuron. 2010; 65(1): 719.
21.Moser, MB, Moser, EI. Functional differentiation in the hippocampus. Hippocampus. 1998; 8(6): 608619.
22.Poppenk, J, Evensmoen, HR, Moscovitch, M, Nadel, L. Long-axis specialization of the human hippocampus. Trends Cogn Sci. 2013; 17(5): 230240.
23.O’Leary, OF, Cryan, JF. A ventral view on antidepressant action: roles for adult hippocampal neurogenesis along the dorsoventral axis. Trends Pharmacol Sci. 2014; 35(12): 675687.
24.Moser, E, Moser, MB, Andersen, P. Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions. J Neurosci. 1993; 13(9): 39163925.
25.Pothuizen, HH, Zhang, WN, Jongen-Relo, AL, Feldon, J, Yee, BK. Dissociation of function between the dorsal and the ventral hippocampus in spatial learning abilities of the rat: a within-subject, within-task comparison of reference and working spatial memory. Eur J Neurosci. 2004; 19(3): 705712.
26.Bannerman, DM, Grubb, M, Deacon, RM, Yee, BK, Feldon, J, Rawlins, JN. Ventral hippocampal lesions affect anxiety but not spatial learning. Behav Brain Res. 2003; 139(1–2): 197213.
27.Bannerman, DM, Rawlins, JN, McHugh, SB, et al. Regional dissociations within the hippocampus—memory and anxiety. Neurosci Biobehav Rev. 2004; 28(3): 273283.
28.Kjelstrup, KG, Tuvnes, FA, Steffenach, HA, Murison, R, Moser, EI, Moser, MB. Reduced fear expression after lesions of the ventral hippocampus. Proc Natl Acad Sci U S A. 2002; 99(16): 1082510830.
29.Rudy, JW, Matus-Amat, P. The ventral hippocampus supports a memory representation of context and contextual fear conditioning: implications for a unitary function of the hippocampus. Behav Neurosci. 2005; 119(1): 154163.
30.Ramon y, Cajal S. Histologie du Systeme Nerveux de l’Homme et des Vertbré Vol II. Paris: Maloine; 1911.
31.Lorente de Nó, R. Studies of the structure of the cerebral cortex. II. Continuation of the study of the ammonic system. Journal für Psychologie und Neurologie. 1934; 46: 113177.
32.Lavenex, P. Functional anatomy, development and pathology of the hippocampus. In: Bartsch T ed. The Clinical Neurobiology of the Hippocampus: An Integrative View. Oxford, UK: Oxford University Press; 2012: 1038.
33.Freund, TF, Buzsáki, G. Interneurons of the hippocampus. Hippocampus. 1996; 6(4): 347470.
34.Parra, P, Gulyas, AI, Miles, R. How many subtypes of inhibitory cells in the hippocampus? Neuron. 1998; 20(5): 983993.
35.Ribak, CE, Nitsch, R, Seress, L. Proportion of parvalbumin-positive basket cells in the GABAergic innervation of pyramidal and granule cells of the rat hippocampal formation. J Comp Neurol. 1990; 300(4): 449461.
36.Sloviter, RS. Calcium-binding protein (calbindin-D28k) and parvalbumin immunocytochemistry: localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity. J Comp Neurol. 1989; 280(2): 183196.
37.Aznar, S, Qian, Z, Shah, R, Rahbek, B, Knudsen, GM. The 5-HT1A serotonin receptor is located on calbindin- and parvalbumin-containing neurons in the rat brain. Brain Res. 2003; 959(1): 5867.
38.Gulyas, AI, Hajos, N, Freund, TF. Interneurons containing calretinin are specialized to control other interneurons in the rat hippocampus. J Neurosci. 1996; 16(10): 33973411.
39.Berumen, LC, Rodriguez, A, Miledi, R, Garcia-Alcocer, G. Serotonin receptors in hippocampus. ScientificWorldJournal. 2012; 2012: 823493.
40.Oleskevich, S, Descarries, L, Watkins, KC, Seguela, P, Daszuta, A. Ultrastructural features of the serotonin innervation in adult rat hippocampus: an immunocytochemical description in single and serial thin sections. Neuroscience. 1991; 42(3): 777791.
41.Umbriaco, D, Garcia, S, Beaulieu, C, Descarries, L. Relational features of acetylcholine, noradrenaline, serotonin and GABA axon terminals in the stratum radiatum of adult rat hippocampus (CA1). Hippocampus. 1995; 5(6): 605620.
42.Vizi, ES, Kiss, JP. Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions. Hippocampus. 1998; 8(6): 566607.
43.Aghajanian, GK, Sanders-Bush, E. Serotonin. In: Davis KL, Charney D, Coyle JT, Nemeroff C eds. Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia: Lippincott, Williams, & Wilkins; 2002.
44.Glennon, RA, Dukat, M, Westkaemper, RB. Serotonin receptor subtypes and ligands. In: Bloom FE, Kupfer DJ eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 2000.
45.Herrick-Davis, K. Functional significance of serotonin receptor dimerization. Exp Brain Res. 2013; 230(4): 375386.
46.Gonzalez-Maeso, J, Ang, RL, Yuen, T, et al. Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature. 2008; 452(7183): 9397.
47.Naumenko, VS, Popova, NK, Lacivita, E, Leopoldo, M, Ponimaskin, EG. Interplay between serotonin 5-HT1A and 5-HT7 receptors in depressive disorders. CNS Neurosci Ther. 2014; 20(7): 582590.
48.Jarrard, LE. On the role of the hippocampus in learning and memory in the rat. Behav Neural Biol. 1993; 60(1): 926.
49.Squire, LR. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev. 1992; 99(2): 195231.
50.Knierim, JJ, Hamilton, DA. Framing spatial cognition: neural representations of proximal and distal frames of reference and their roles in navigation. Physiological Rev. 2011; 91(4): 12451279.
51.Luscher, C, Jan, LY, Stoffel, M, Malenka, RC, Nicoll, RA. G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron. 1997; 19(3): 687695.
52.Pompeiano, M, Palacios, JM, Mengod, G. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci. 1992; 12(2): 440453.
53.Andrade, R, Nicoll, RA. Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro. J Physiol. 1987; 394: 99124.
54.Beck, SG, Clarke, WP, Goldfarb, J. Spiperone differentiates multiple 5-hydroxytryptamine responses in rat hippocampal slices in vitro. Eur J Pharmacol. 1985; 116(1–2): 195197.
55.Chaput, Y, Araneda, RC, Andrade, R. Pharmacological and functional analysis of a novel serotonin receptor in the rat hippocampus. Eur J Pharmacol. 1990; 182(3): 441456.
56.Haddjeri, N, Blier, P, de Montigny, C. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neursci. 1998; 18(23): 1015010156.
57.Johnston, A, McBain, CJ, Fisahn, A. 5-Hydroxytryptamine1A receptor-activation hyperpolarizes pyramidal cells and suppresses hippocampal gamma oscillations via Kir3 channel activation. J Physiol. 2014; 592(Pt 19): 41874199.
58.Kasamo, K, Suzuki, T, Tada, K, et al. Endogenous 5-HT tonically inhibits spontaneous firing activity of dorsal hippocampus CA1 pyramidal neurons through stimulation of 5-HT(1A) receptors in quiet awake rats: in vivo electrophysiological evidence. Neuropsychopharmacology. 2001; 24(2): 141151.
59.Tada, K, Kasamo, K, Suzuki, T, Matsuzaki, Y, Kojima, T. Endogenous 5-HT inhibits firing activity of hippocampal CA1 pyramidal neurons during conditioned fear stress-induced freezing behavior through stimulating 5-HT1A receptors. Hippocampus. 2004; 14(2): 143147.
60.Llado-Pelfort, L, Santana, N, Ghisi, V, Artigas, F, Celada, P. 5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons. Cereb Cortex. 2012; 22(7): 14871497.
61.Haider, S, Khaliq, S, Tabassum, S, Haleem, DJ. Role of somatodendritic and postsynaptic 5-HT(1)A receptors on learning and memory functions in rats. Neurochem Res. 2012; 37(10): 21612166.
62.Newman-Tancredi, A, Martel, JC, Assie, MB, et al. Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist. Br J Pharmacol. 2009; 156(2): 338353.
63.Boschert, U, Amara, DA, Segu, L, Hen, R. The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience. 1994; 58(1): 167182.
64.Bruinvels, AT, Landwehrmeyer, B, Gustafson, EL, et al. Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacology. 1994; 33(3–4): 367386.
65.Sari, Y, Lefevre, K, Bancila, M, et al. Light and electron microscopic immunocytochemical visualization of 5-HT1B receptors in the rat brain. Brain Res. 1997; 760(1–2): 281286.
66.Bruinvels, AT, Palacios, JM, Hoyer, D. Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1993; 347(6): 569582.
67.Xie, Z, Lee, SP, O’Dowd, BF, George, SR. Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed. FEBS Lett. 1999; 456(1): 6367.
68.Boeijinga, PH, Boddeke, HW. Serotonergic modulation of neurotransmission in the rat subicular cortex in vitro: a role for 5-HT1B receptors. Naunyn Schmiedebergs Arch Pharmacol. 1993; 348(6): 553557.
69.Mlinar, B, Falsini, C, Corradetti, R. Pharmacological characterization of 5-HT(1B) receptor-mediated inhibition of local excitatory synaptic transmission in the CA1 region of rat hippocampus. Br J Pharmacol. 2003; 138(1): 7180.
70.Hu, XJ, Wang, FH, Stenfors, C, Ogren, SO, Kehr, J. Effects of the 5-HT1B receptor antagonist NAS-181 on extracellular levels of acetylcholine, glutamate and GABA in the frontal cortex and ventral hippocampus of awake rats: a microdialysis study. Eur Neuropsychopharmacol. 2007; 17(9): 580586.
71.Bombardi, C. Neuronal localization of 5-HT2A receptor immunoreactivity in the rat hippocampal region. Brain Res Bull. 2012; 87(2–3): 259273.
72.Cornea-Hebert, V, Riad, M, Wu, C, Singh, SK, Descarries, L. Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol. 1999; 409(2): 187209.
73.Luttgen, M, Ove Ogren, S, Meister, B. Chemical identity of 5-HT2A receptor immunoreactive neurons of the rat septal complex and dorsal hippocampus. Brain Res. 2004; 1010(1–2): 156165.
74.Shen, RY, Andrade, R. 5-Hydroxytryptamine2 receptor facilitates GABAergic neurotransmission in rat hippocampus. J Pharmacol Exp Ther. 1998; 285(2): 805812.
75.Wang, RY, Arvanov, VL. M100907, a highly selective 5-HT2A receptor antagonist and a potential atypical antipsychotic drug, facilitates induction of long-term potentiation in area CA1 of the rat hippocampal slice. Brain Res. 1998; 779(1–2): 309313.
76.Morales, M, Battenberg, E, de Lecea, L, Bloom, FE. The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus. Brain Res. 1996; 731(1–2): 199202.
77.Morales, M, Battenberg, E, de Lecea, L, Sanna, PP, Bloom, FE. Cellular and subcellular immunolocalization of the type 3 serotonin receptor in the rat central nervous system. Brain Res Mol Brain Res. 1996; 36(2): 251260.
78.Bloom, FE, Morales, M. The central 5-HT3 receptor in CNS disorders. Neurochem Res. 1998; 23(5): 653659.
79.Morales, M, Bloom, FE. The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon. J Neurosci. 1997; 17(9): 31573167.
80.Kawa, K. Distribution and functional properties of 5-HT3 receptors in the rat hippocampal dentate gyrus: a patch-clamp study. J Neurophysiol. 1994; 71(5): 19351947.
81.McMahon, LL, Kauer, JA. Hippocampal interneurons are excited via serotonin-gated ion channels. J Neurophysiol. 1997; 78(5): 24932502.
82.Dale, E, Zhang, H, Leiser, SC, et al. Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus. J Psychopharmacol. 2014; 28(10): 891902.
83.Passani, MB, Pugliese, AM, Azzurrini, M, Corradetti, R. Effects of DAU 6215, a novel 5-hydroxytryptamine3 (5-HT3) antagonist on electrophysiological properties of the rat hippocampus. Br J Pharmacol. 1994; 112(2): 695703.
84.Ropert, N, Guy, N. Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro. J Physiol. 1991; 441(1): 121136.
85.Turner, TJ, Mokler, DJ, Luebke, JI. Calcium influx through presynaptic 5-HT3 receptors facilitates GABA release in the hippocampus: in vitro slice and synaptosome studies. Neuroscience. 2004; 129(3): 703718.
86.Reznic, J, Staubli, U. Effects of 5-HT3 receptor antagonism on hippocampal cellular activity in the freely moving rat. J Neurophysiol. 1997; 77(1): 517521.
87.Staubli, U, Otaky, N. Serotonin controls the magnitude of LTP induced by theta bursts via an action on NMDA-receptor-mediated responses. Brain Res. 1994; 643(1–2): 1016.
88.Staubli, U, Xu, FB. Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat. J Neurosci. 1995; 15(3 Pt 2): 24452452.
89.Vilaro, MT, Cortes, R, Mengod, G. Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain: distribution and effects of neurotoxic lesions. J Comp Neurol. 2005; 484(4): 418439.
90.Waeber, C, Sebben, M, Nieoullon, A, Bockaert, J, Dumuis, A. Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain. Neuropharmacology. 1994; 33(3–4): 527541.
91.Peñas-Cazorla, R, Vilaró, MT. Serotonin 5-HT receptors and forebrain cholinergic system: receptor expression in identified cell populations. Brain Struct Funct. In press. DOI: 10.1007/s00429-014-0864-z.
92.Chapin, EM, Haj-Dahmane, S, Torres, G, Andrade, R. The 5-HT(4) receptor-induced depolarization in rat hippocampal neurons is mediated by cAMP but is independent of I(h). Neurosci Lett. 2002; 324(1): 14.
93.Mlinar, B, Mascalchi, S, Mannaioni, G, Morini, R, Corradetti, R. 5-HT4 receptor activation induces long-lasting EPSP-spike potentiation in CA1 pyramidal neurons. Eur J Nneurosci. 2006; 24(3): 719731.
94.Matsumoto, M, Togashi, H, Mori, K, et al. Evidence for involvement of central 5-HT(4) receptors in cholinergic function associated with cognitive processes: behavioral, electrophysiological, and neurochemical studies. J Pharmacol Exp Ther. 2001; 296(3): 676682.
95.Oliver, KR, Kinsey, AM, Wainwright, A, Sirinathsinghji, DJ. Localization of 5-ht(5A) receptor-like immunoreactivity in the rat brain. Brain Res. 2000; 867(1–2): 131142.
96.Kinsey, AM, Wainwright, A, Heavens, R, Sirinathsinghji, DJ, Oliver, KR. Distribution of 5-ht(5A), 5-ht(5B), 5-ht(6) and 5-HT(7) receptor mRNAs in the rat brain. Brain Res Mol Brain Res. 2001; 88(1–2): 194198.
97.Gerard, C, Martres, MP, Lefevre, K, et al. Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Res. 1997; 746(1–2): 207219.
98.de Jong, I, Helboe, L. Distribution of serotonin receptor 5-HT6 mRNA in selected neuronal populations in rat brain: a double-labelling in situ hybridization study. Alzheimer’s & Dementia. 2014; 10(4 Suppl): 925926.
99.West, PJ, Marcy, VR, Marino, MJ, Schaffhauser, H. Activation of the 5-HT(6) receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus. Neuroscience. 2009; 164(2): 692701.
100.Schechter, LE, Lin, Q, Smith, DL, et al. Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466. Neuropsychopharmacol. 2008; 33(6): 13231335.
101.Dawson, LA, Nguyen, HQ, Li, P. The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology. 2001; 25(5): 662668.
102.Pehrson, AL, Sanchez, C. Altered gamma-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants. Drug Des Devel Ther. 2015; 9: 603624.
103.Wilkinson, D, Windfeld, K, Colding-Jorgensen, E. Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer’s disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 2014; 13(11): 10921099.
104.Neumaier, JF, Sexton, TJ, Yracheta, J, Diaz, AM, Brownfield, M. Localization of 5-HT(7) receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression. J Chem Neuroanat. 2001; 21(1): 6373.
105.Garcia-Alcocer, G, Segura, LC, Garcia Pena, M, Martinez-Torres, A, Miledi, R. Ontogenetic distribution of 5-HT2C, 5-HT5A, and 5-HT7 receptors in the rat hippocampus. Gene Expr. 2006; 13(1): 5357.
106.Kobe, F, Guseva, D, Jensen, TP, et al. 5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J Neurosci. 2012; 32(9): 29152930.
107.Muneoka, KT, Takigawa, M. 5-Hydroxytryptamine7 (5-HT7) receptor immunoreactivity-positive ‘stigmoid body’-like structure in developing rat brains. Int J Dev Neurosci. 2003; 21(3): 133143.
108.Ciranna, L. Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology. Curr Neuropharmacol. 2006; 4(2): 101114.
109.Costa, L, Trovato, C, Musumeci, SA, Catania, MV, Ciranna, L. 5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission. Hippocampus. 2012; 22(4): 790801.
110.Gill, CH, Soffin, EM, Hagan, JJ, Davies, CH. 5-HT7 receptors modulate synchronized network activity in rat hippocampus. Neuropharmacology. 2002; 42(1): 8292.
111.Tokarski, K, Zahorodna, A, Bobula, B, Hess, G. 5-HT7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons. Brain Res. 2003; 993(1–2): 230234.
112.Tokarski, K, Kusek, M, Hess, G. 5-HT7 receptors modulate GABAergic transmission in rat hippocampal CA1 area. J Physiol Pharmacol. 2011; 62(5): 535540.
113.Gasbarri, A, Pompili, A. Serotonergic 5-HT7 receptors and cognition. Rev Neurosci. 2014; 25(3): 311323.
114.Meneses, A. Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative. Rev Neurosci. 2014; 25(3): 325356.
115.Chaput, Y, Lesieur, P, de Montigny, C. Effects of short-term serotonin depletion on the efficacy of serotonin neurotransmission: electrophysiological studies in the rat central nervous system. Synapse. 1990; 6(4): 328337.
116.Ferraro, G, Montalbano, ME, Sardo, P, La Grutta, V. Lateral habenula and hippocampus: a complex interaction raphe cells-mediated. J Neural Transm. 1997; 104(6–7): 615631.
117.Segal, M. Physiological and pharmacological evidence for a serotonergic projection to the hippocampus. Brain Res. 1975; 94(1): 115131.
118.Segal, M. 5-HT antagonists in rat hippocampus. Brain Res. 1976; 103(1): 161166.
119.Andrade, R, Chaput, Y. 5-Hydroxytryptamine4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus. J Pharmacol Exp Ther. 1991; 257(3): 930937.
120.Piguet, P, Galvan, M. Transient and long-lasting actions of 5-HT on rat dentate gyrus neurones in vitro. J Physiol. 1994; 481(Pt 3): 629639.
121.Cremers, TI, Rea, K, Bosker, FJ, et al. Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies. Neuropsychopharmacology. 2007; 32(7): 15501557.
122.Haider, S, Khaliq, S, Ahmed, SP, Haleem, DJ. Long-term tryptophan administration enhances cognitive performance and increases 5HT metabolism in the hippocampus of female rats. Amino Acids. 2006; 31(4): 421425.
123.Hervas, I, Artigas, F. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors. Eur J Pharmacol. 1998; 358(1): 918.
124.Le Poul, E, Boni, C, Hanoun, N, et al. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology. 2000; 39(1): 110122.
125.Blier, P, de Montigny, C, Chaput, Y. A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. J Clin Psychiatry. 1990; 51(Suppl): 1420; discussion 21.
126.Chaput, Y, de Montigny, C, Blier, P. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. Neuropsychopharmacology. 1991; 5(4): 219229.
127.Malenka, RC, Nicoll, RA. Long-term potentiation—a decade of progress? Science. 1999; 285(5435): 18701874.
128.Corradetti, R, Ballerini, L, Pugliese, AM, Pepeu, G. Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices. Neuroscience. 1992; 46(3): 511518.
129.Mnie-Filali, O, El Mansari, M, Espana, A, Sanchez, C, Haddjeri, N. Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity. Neurosci Lett. 2006; 395(1): 2327.
130.Ryan, B, Musazzi, L, Mallei, A, et al. Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression. Int J Neuropsychopharmacol. 2009; 12(4): 553559.
131.Shakesby, AC, Anwyl, R, Rowan, MJ. Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents. J Neurosci. 2002; 22(9): 36383644.
132.Stewart, CA, Reid, IC. Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity. Psychopharmacology (Berl). 2000; 148(3): 217223.
133.Pittenger, C, Duman, RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology. 2008; 33(1): 88109.
134.Popoli, M, Gennarelli, M, Racagni, G. Modulation of synaptic plasticity by stress and antidepressants. Bipolar Disord. 2002; 4(3): 166182.
135.Holderbach, R, Clark, K, Moreau, JL, Bischofberger, J, Normann, C. Enhanced long-term synaptic depression in an animal model of depression. Biol Psychiatry. 2007; 62(1): 92100.
136.Matsumoto, M, Tachibana, K, Togashi, H, et al. Chronic treatment with milnacipran reverses the impairment of synaptic plasticity induced by conditioned fear stress. Psychopharmacology (Berl). 2005; 179(3): 606612.
137.Godlewska, BR, Norbury, R, Selvaraj, S, Cowen, PJ, Harmer, CJ. Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients. Psychol Med. 2012; 42(12): 26092617.
138.Herzallah, MM, Moustafa, AA, Natsheh, JY, et al. Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder. J Affect Disord. 2013; 151(2): 484492.
139.Olivier, B. Serotonin: a never-ending story. Eur J Pharmacol. 2015; 753: 218.
140.Kirchhoff, VD, Nguyen, HT, Soczynska, JK, Woldeyohannes, HO, McIntyre, RS. Discontinued psychiatric drugs in 2008. Expert Opin Investig Drugs. 2009; 18(10): 14311443.
141.Westrich, L, Pehrson, A, Zhong, H, et al. In vitro and in vivo effects of the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets. Int J Psych Clin Pract. 2012; 5(Suppl 1): 47.
142.Bang-Andersen, B, Ruhland, T, Jorgensen, M, et al. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. J Med Chem. 2011; 54(9): 32063221.
143.Katona, C, Hansen, T, Olsen, CK. A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. Int Clin Psychopharmacol. 2012; 27(4): 215223.
144.McIntyre, RS, Lophaven, S, Olsen, CK. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol. 2014; 17(10): 15571567.
145.Mahableshwarkar, AR, Zajecka, J, Jacobson, W, Chen, Y, Keefe, RS. A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology. 2015; 40(8): 20252037.
146.Browning, M, Smith, J, Conen, S, et al. Vortioxetine reduces BOLD signal during performance of the N-Back task in subjects remitted from depression and healthy control participants. Neuropsychopharm. 2014; 39(Supplement 1): S480.
147.Sanchez, C, Asin, KE, Artigas, F. Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data. Pharmacol Ther. 2015; 145: 4357.
148.Mork, A, Pehrson, A, Brennum, LT, et al. Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder. J Pharmacol Exp Ther. 2012; 340(3): 666675.
149.Pehrson, AL, Cremers, T, Betry, C, et al. Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters—a rat microdialysis and electrophysiology study. Eur Neuropsychopharmacol. 2013; 23(2): 133145.
150.Puig, MV, Santana, N, Celada, P, Mengod, G, Artigas, F. In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors. Cereb Cortex. 2004; 14(12): 13651375.
151.Riga, MS, Celada, P, Sanchez, C, Artigas, F. Cortical and hippocampal microcircuits involved in the mechanism of action of the new antidepressant drug vortioxetine. Neuropsychopharm. 2014; 39(Supplement 1): S632.
152.El Mansari, M, Lecours, M, Blier, P. Effects of acute and sustained administration of vortioxetine on the serotonin system in the hippocampus: electrophysiological studies in the rat brain. Psychopharmacology (Berl). 2015; 232(13): 23432352.
153.O’Mara, SM, Sanchez-Vives, MV, Brotons-Mas, JR, O’Hare, E. Roles for the subiculum in spatial information processing, memory, motivation and the temporal control of behaviour. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33(5): 782790.
154.Sari, Y. Serotonin1B receptors: from protein to physiological function and behavior. Neurosci Biobehav Rev. 2004; 28(6): 565582.
155.Smagin, G, Song, D, Budac, DP, Pehrson, A, Li, Y, Sanchez, C. Chronic treatment with vortioxetine activates the central histaminergic system: a microdialysis study in rats. Biol Psychiatry. 2014; 75(9), Supplement, 391S.
156.Li, Y, Abdourahman, A, Tamm, JA, et al. Reversal of age-associated cognitive deficits is accompanied by increased plasticity-related gene expression after chronic antidepressant administration in middle-aged mice. Pharmacol Biochem Behav. 2015; 135: 7082.
157.Bétry, C, Etiévant, A, Pehrson, A, Sanchez, C, Haddjeri, N. Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory. Prog Neuropsychopharmacol Biol Psychiatry. 2015; 58: 3846.
158.Guilloux, JP, Mendez-David, I, Pehrson, A, et al. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice. Neuropharmacology. 2013; 73: 147159.
159.Sanacora, G, Banasr, M. From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol Psychiatry. 2013; 73(12): 11721179.
160.Sanacora, G, Treccani, G, Popoli, M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology. 2012; 62(1): 6377.
161.Pehrson, AL, Sanchez, C. Vortioxetine reverses social recognition memory impairments induced by acetylcholine or glutamate dysregulation in rats. Eur Neuropsychopharmacol. 2014; 24(Supplement 2): S369.
162.Bétry, C, Pehrson, AL, Etiévant, A, Ebert, B, Sánchez, C, Haddjeri, N. The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism. Int J Neuropsychopharmacol. 2013; 16(5): 11151127.
163.Pompeiano, M, Palacios, JM, Mengod, G. Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res. 1994; 23(1–2): 163178.
164.Haider, S, Khaliq, S, Haleem, DJ. Enhanced serotonergic neurotransmission in the hippocampus following tryptophan administration improves learning acquisition and memory consolidation in rats. Pharmacol Rep. 2007; 59(1): 5357.
165.Levkovitz, Y, Richter-Levin, G, Segal, M. Effect of 5-hydroxytryptophane on behavior and hippocampal physiology in young and old rats. Neurobiol Aging. 1994; 15(5): 635641.
166.Egashira, N, Mishima, K, Katsurabayashi, S, et al. Involvement of 5-hydroxytryptamine neuronal system in Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory. Eur J Pharmacol. 2002; 445(3): 221229.
167.Inoue, T, Kitaichi, Y, Koyama, T. SSRIs and conditioned fear. Prog Neuropsychopharmacol Biol Psychiatry. 2011; 35(8): 18101819.
168.Karabeg, MM, Grauthoff, S, Kollert, SY, et al. 5-HTT deficiency affects neuroplasticity and increases stress sensitivity resulting in altered spatial learning performance in the Morris water maze but not in the Barnes maze. PloS one. 2013; 8(10): e78238.
169.Nonkes, LJ, de Pooter, M, Homberg, JR. Behavioural therapy based on distraction alleviates impaired fear extinction in male serotonin transporter knockout rats. J Psychiatry Neurosci. 2012; 37(4): 224230.
170.Luoni, A, Hulsken, S, Cazzaniga, G, Racagni, G, Homberg, JR, Riva, MA. Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats. Int J Neuropsychopharmacol. 2013; 16(6): 13191330.
171.Ampuero, E, Stehberg, J, Gonzalez, D, et al. Repetitive fluoxetine treatment affects long-term memories but not learning. Behav Brain Res. 2013; 247: 92100.
172.Sass, A, Wortwein, G. The effect of subchronic fluoxetine treatment on learning and memory in adolescent rats. Behav Brain Res. 2012; 228(1): 169175.
173.Gumuslu, E, Mutlu, O, Sunnetci, D, et al. The effects of tianeptine, olanzapine and fluoxetine on the cognitive behaviors of unpredictable chronic mild stress-exposed mice. Drug Res. 2013; 63(10): 532539.
174.Valluzzi, JA, Chan, K. Effects of fluoxetine on hippocampal-dependent and hippocampal-independent learning tasks. Behav Pharmacol. 2007; 18(5–6): 507513.
175.Heinen, M, Hettich, MM, Ryan, DP, Schnell, S, Paesler, K, Ehninger, D. Adult-onset fluoxetine treatment does not improve behavioral impairments and may have adverse effects on the Ts65Dn mouse model of Down syndrome. Neural Plasticity. 2012; 2012: Article 467251.
176.Myint, AM, O’Mahony, S, Kubera, M, et al. Role of paroxetine in interferon-alpha-induced immune and behavioural changes in male Wistar rats. J Psychopharmacol. 2007; 21(8): 843850.
177.Wang, Y, Neumann, M, Hansen, K, et al. Fluoxetine increases hippocampal neurogenesis and induces epigenetic factors but does not improve functional recovery after traumatic brain injury. J Neurotrauma. 2011; 28(2): 259268.
178.Naudon, L, Hotte, M, Jay, TM. Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine. Psychopharmacology (Berl). 2007; 191(2): 353364.
179.Egashira, N, Matsumoto, Y, Mishima, K, et al. Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization. Pharmacol Biochem Behav. 2006; 83(1): 161167.
180.Montezinho, LP, Miller, S, Plath, N, et al. The effects of acute treatment with escitalopram on the different stages of contextual fear conditioning are reversed by atomoxetine. Psychopharmacology (Berl). 2010; 212(2): 131143.
181.Bridoux, A, Laloux, C, Derambure, P, Bordet, R, Monaca Charley, C. The acute inhibition of rapid eye movement sleep by citalopram may impair spatial learning and passive avoidance in mice. J Neural Transm. 2013; 120(3): 383389.
182.Jensen, JB, du Jardin, KG, Song, D, et al. Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation. Eur Neuropsychopharmacol. 2014; 24(1): 148159.
183.Mørk, A, Montezinho, LP, Miller, S, et al. Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats. Pharmacol Biochem Behav. 2013; 105: 4150.
184.du Jardin, KG, Jensen, JB, Sanchez, C, Pehrson, AL. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism. Eur Neuropsychopharmacol. 2014; 24(1): 160171.
185.Adams, W, Kusljic, S, van den Buuse, M. Serotonin depletion in the dorsal and ventral hippocampus: effects on locomotor hyperactivity, prepulse inhibition and learning and memory. Neuropharmacology. 2008; 55(6): 10481055.
186.Lehmann, O, Bertrand, F, Jeltsch, H, et al. 5,7-DHT-induced hippocampal 5-HT depletion attenuates behavioural deficits produced by 192 IgG-saporin lesions of septal cholinergic neurons in the rat. Eur J Neurosci. 2002; 15(12): 19912006.
187.Lehmann, O, Jeltsch, H, Lazarus, C, Tritschler, L, Bertrand, F, Cassel, JC. Combined 192 IgG-saporin and 5,7-dihydroxytryptamine lesions in the male rat brain: a neurochemical and behavioral study. Pharmacol Biochem Behav. 2002; 72(4): 899912.
188.Lehmann, O, Jeltsch, H, Lehnardt, O, Pain, L, Lazarus, C, Cassel, JC. Combined lesions of cholinergic and serotonergic neurons in the rat brain using 192 IgG-saporin and 5,7-dihydroxytryptamine: neurochemical and behavioural characterization. Eur J Neurosci. 2000; 12(1): 6779.
189.Murtha, SJ, Pappas, BA. Neurochemical, histopathological and mnemonic effects of combined lesions of the medial septal and serotonin afferents to the hippocampus. Brain Res. 1994; 651(1–2): 1626.
190.Volpe, BT, Hendrix, CS, Park, DH, Towle, AC, Davis, HP. Early post-natal administration of 5,7-dihydroxytryptamine destroys 5-HT neurons but does not affect spatial memory. Brain Res. 1992; 589(2): 262267.
191.Gutierrez-Guzman, BE, Hernandez-Perez, JJ, Lopez-Vazquez, MA, Fregozo, CS, Guevara, MA, Olvera-Cortes, ME. Serotonin depletion of supramammillary/posterior hypothalamus nuclei produces place learning deficiencies and alters the concomitant hippocampal theta activity in rats. Eur J Pharmacol. 2012; 682(1–3): 99109.
192.Richter-Levin, G, Greenberger, V, Segal, M. The effects of general and restricted serotonergic lesions on hippocampal electrophysiology and behavior. Brain Res. 1994; 642(1–2): 111116.
193.Kenton, L, Boon, F, Cain, DP. Combined but not individual administration of beta-adrenergic and serotonergic antagonists impairs water maze acquisition in the rat. Neuropsychopharmacology. 2008; 33(6): 12981311.
194.Galani, R, Berthel, MC, Lazarus, C, et al. The behavioral effects of enriched housing are not altered by serotonin depletion but enrichment alters hippocampal neurochemistry. Neurobiol Learn Mem. 2007; 88(1): 110.
195.Lieben, CK, van Oorsouw, K, Deutz, NE, Blokland, A. Acute tryptophan depletion induced by a gelatin-based mixture impairs object memory but not affective behavior and spatial learning in the rat. Behav Brain Res. 2004; 151(1–2): 5364.
196.Uchida, S, Umeeda, H, Kitamoto, A, Masushige, S, Kida, S. Chronic reduction in dietary tryptophan leads to a selective impairment of contextual fear memory in mice. Brain Res. 2007; 1149: 149156.
197.Dai, JX, Han, HL, Tian, M, et al. Enhanced contextual fear memory in central serotonin-deficient mice. Proc Natl Acad Sci U S A. 2008; 105(33): 1198111986.
198.Bert, B, Dere, E, Wilhelmi, N, et al. Transient overexpression of the 5-HT1A receptor impairs water-maze but not hole-board performance. Neurobiol Learn Mem. 2005; 84(1): 5768.
199.Bert, B, Voigt, JP, Kusserow, H, Theuring, F, Rex, A, Fink, H. Increasing the number of 5-HT(1A)-receptors in cortex and hippocampus does not induce mnemonic deficits in mice. Pharmacol Biochem Behav. 2009; 92(1): 7681.
200.Wolff, M, Costet, P, Gross, C, Hen, R, Segu, L, Buhot, MC. Age-dependent effects of serotonin-1A receptor gene deletion in spatial learning abilities in mice. Brain Res Mol Brain Res. 2004; 130(1–2): 3948.
201.Klemenhagen, KC, Gordon, JA, David, DJ, Hen, R, Gross, CT. Increased fear response to contextual cues in mice lacking the 5-HT1A receptor. Neuropsychopharmacology. 2006; 31(1): 101111.
202.Malá, H, Arnberg, K, Chu, D, Nedergaard, SK, Witmer, J, Mogensen, J. Only repeated administration of the serotonergic agonist 8-OH-DPAT improves place learning of rats subjected to fimbria-fornix transection. Pharmacol Biochem Behav. 2013; 109: 5058.
203.Winter, JC, Petti, DT. The effects of 8-hydroxy-2-(di-n-propylamino)tetralin and other serotonergic agonists on performance in a radial maze: a possible role for 5-HT1A receptors in memory. Pharmacol Biochem Behav. 1987; 27(4): 625628.
204.Helsley, S, Siegel, TL, Fiorella, D, Rabin, RA, Winter, JC. WAY-100635 reverses 8-OH-DPAT-induced performance impairment in the radial maze. Prog Neuropsychopharmacol Biol Psychiatry. 1998; 22(7): 11791184.
205.Egashira, N, Yano, A, Ishigami, N, et al. Investigation of mechanisms mediating 8-OH-DPAT-induced impairment of spatial memory: involvement of 5-HT1A receptors in the dorsal hippocampus in rats. Brain Res. 2006; 1069(1): 5462.
206.Inui, K, Egashira, N, Mishima, K, et al. The serotonin1A receptor agonist 8-OHDPAT reverses delta 9-tetrahydrocannabinol-induced impairment of spatial memory and reduction of acetylcholine release in the dorsal hippocampus in rats. Neurotox Res. 2004; 6(2): 153158.
207.Buhot, MC, Patra, SK, Naili, S. Spatial memory deficits following stimulation of hippocampal 5-HT1B receptors in the rat. Eur J Pharmacol. 1995; 285(3): 221228.
208.Bauer, EP. Serotonin in fear conditioning processes. Behav Brain Res. 2015; 277c: 6877.
209.Youn, J, Misane, I, Eriksson, TM, et al. Bidirectional modulation of classical fear conditioning in mice by 5-HT(1A) receptor ligands with contrasting intrinsic activities. Neuropharmacology. 2009; 57(5–6): 567576.
210.Hirst, WD, Andree, TH, Aschmies, S, et al. Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405). J Pharmacol Exp Ther. 2008; 325(1): 134145.
211.McDevitt, RA, Hiroi, R, Mackenzie, SM, et al. Serotonin 1B autoreceptors originating in the caudal dorsal raphe nucleus reduce expression of fear and depression-like behavior. Biol Psychiatry. 2011; 69(8): 780787.
212.Wolff, M, Savova, M, Malleret, G, Hen, R, Segu, L, Buhot, MC. Serotonin 1B knockout mice exhibit a task-dependent selective learning facilitation. Neurosci Lett. 2003; 338(1): 14.
213.Malleret, G, Hen, R, Guillou, JL, Segu, L, Buhot, MC. 5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze. J Neurosci. 1999; 19(14): 61576168.
214.Ahlander-Luttgen, M, Madjid, N, Schott, PA, Sandin, J, Ogren, SO. Analysis of the role of the 5-HT1B receptor in spatial and aversive learning in the rat. Neuropsychopharmacology. 2003; 28(9): 16421655.
215.Fedotova, YO, Ordyan, NE. Blockade of 5-HT2A/2C-type receptors impairs learning in female rats in the course of estrous cycle. Bull Exp Biol Med. 2010; 150(1): 68.
216.Naghdi, N, Harooni, HE. The effect of intrahippocampal injections of ritanserin (5HT2A/2C antagonist) and granisetron (5HT3 antagonist) on learning as assessed in the spatial version of the water maze. Behav Brain Res. 2005; 157(2): 205210.
217.Levin, E, Icenogle, L, Farzad, A. Ketanserin attenuates nicotine-induced working memory improvement in rats. Pharmacol Biochem Behav. 2005; 82(2): 289292.
218.Cohen, H. Anxiolytic effect and memory improvement in rats by antisense oligodeoxynucleotide to 5-hydroxytryptamine-2A precursor protein. Depress Anxiety. 2005; 22(2): 8493.
219.Zhang, G, Ásgeirsdóttir, HN, Cohen, SJ, Munchow, AH, Barrera, MP, Stackman, RW Jr. Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice. Neuropharmacology. 2013; 64: 403413.
220.Tecott, LH, Logue, SF, Wehner, JM, Kauer, JA. Perturbed dentate gyrus function in serotonin 5-HT2C receptor mutant mice. Proc Natl Acad Sci U S A. 1998; 95(25): 1502615031.
221.Burghardt, NS, Bush, DE, McEwen, BS, LeDoux, JE. Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist. Biol Psychiatry. 2007; 62(10): 11111118.
222.Hodges, H, Sowinski, P, Sinden, JD, Netto, CA, Fletcher, A. The selective 5-HT3 receptor antagonist, WAY100289, enhances spatial memory in rats with ibotenate lesions of the forebrain cholinergic projection system. Psychopharmacology (Berl). 1995; 117(3): 318332.
223.Pitsikas, N, Brambilla, A, Borsini, F. Effect of DAU 6215, a novel 5-HT3 receptor antagonist, on scopolamine-induced amnesia in the rat in a spatial learning task. Pharmacol Biochem Behav. 1994; 47(1): 9599.
224.Harrell, AV, Allan, AM. Improvements in hippocampal-dependent learning and decremental attention in 5-HT(3) receptor overexpressing mice. Learn Mem. 2003; 10(5): 410419.
225.Segu, L, Lecomte, MJ, Wolff, M, et al. Hyperfunction of muscarinic receptor maintains long-term memory in 5-HT4 receptor knock-out mice. PloS one. 2010; 5(3): e9529.
226.Cachard-Chastel, M, Devers, S, Sicsic, S, et al. Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice. Behav Brain Res. 2008; 187(2): 455461.
227.Orsetti, M, Dellarole, A, Ferri, S, Ghi, P. Acquisition, retention, and recall of memory after injection of RS67333, a 5-HT(4) receptor agonist, into the nucleus basalis magnocellularis of the rat. Learn Mem. 2003; 10(5): 420426.
228.Fontana, DJ, Daniels, SE, Wong, EH, Clark, RD, Eglen, RM. The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigation. Neuropharmacology. 1997; 36(4–5): 689696.
229.Woolley, ML, Bentley, JC, Sleight, AJ, Marsden, CA, Fone, KC. A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology. 2001; 41(2): 210219.
230.Rogers, DC, Hagan, JJ. 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology (Berl). 2001; 158(2): 114119.
231.Stean, TO, Hirst, WD, Thomas, DR, et al. Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonist. Pharmacol Biochem Behav. 2002; 71(4): 645654.
232.Lindner, MD, Hodges, DB Jr., Hogan, JB, et al. An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning. J Pharmacol Exp Ther. 2003; 307(2): 682691.
233.Roberts, AJ, Hedlund, PB. The 5-HT(7) receptor in learning and memory. Hippocampus. 2012; 22(4): 762771.
234.Gasbarri, A, Cifariello, A, Pompili, A, Meneses, A. Effect of 5-HT(7) antagonist SB-269970 in the modulation of working and reference memory in the rat. Behav Brain Res. 2008; 195(1): 164170.

Keywords

Related content

Powered by UNSILO